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ABSTRACT
Introduction: In the general population, alcohol use
disorder and depression more often occur together
than any other combination of a mental illness with a
substance use disorder. It is important to have a cost-
effective intervention that is able to reach at-risk
individuals in the early stages of developing alcohol
use disorders and depression disorders.
Methods and analysis: This paper presents the
protocol for a 3-arm multicentre randomised controlled
trial (RCT) to test the efficacy and cost-effectiveness of
the combined internet-based self-help intervention Take
Care of You (TCOY) to reduce alcohol misuse and
depression symptoms in comparison with a waiting list
control group and a comparable intervention focusing
on problematic alcohol use only. The active
interventions consist of modules designed to reduce
alcohol use, based on the principles of motivational
interviewing and methods of cognitive behavioural
therapy, together with additional modules in the
combined study arm to reduce symptoms of
depression. Data will be collected at baseline, as well
as at 3 and 6 months postrandomisation. The primary
outcome is the quantity of alcohol used in the past
7 days. A number of secondary outcome measures will
be studied. These include the Centre of Epidemiologic
Studies of Depression Scale (CES-D) and a combined
measure with the criteria of values below the cut-off
for severe alcohol use disorder and for CES-D. Data
analysis will follow the intention-to-treat principle using
(generalised) linear mixed models. In order to
investigate the interventions’ cost-utility and cost-
effectiveness, a full economic evaluation will be
performed.
Ethics and dissemination: This RCT will be
executed in compliance with the Helsinki Declaration
and has been approved by 2 local Ethics Committees.
Results will be reported at conferences and in peer-
reviewed publications. Participant-friendly summaries of
trial findings will be published on the TCOY websites.
Trial registration number: ISRCTN10323951.
INTRODUCTION
Mental disorders constitute a major burden
of disease with signiﬁcant effects on physical
health and major social and economic conse-
quences. Mental disorders, such as alcohol
use disorder and depression, are chronic
intermittent conditions that may affect, and
are affected by, other chronic diseases, such
as cancer and cardiovascular disease.1 Taken
together, substance use and other mental dis-
orders account for 7.4% of the total global
burden of disease.2 Alcohol misuse alone
accounts for 5.1% of the global burden of
disease and 5.9% of all deaths worldwide.3
Alcohol misuse in the present protocol is
deﬁned as a score of 8 or more on the
Alcohol Use Disorder Identiﬁcation Test
(AUDIT4).
Co-occurring disorders are also called dual
disorders, dual diagnosis or comorbid disor-
ders and are diagnosed if at least two
Strengths and limitations of this study
▪ Take Care of You (TCOY) is a multicentre rando-
mised controlled trial to assess the efficacy and
cost-effectiveness of an internet-based self-help
intervention that aims to reduce problematic
alcohol use and depression symptoms
simultaneously.
▪ A strength of the present study is that the effects
of the intervention on alcohol use (disorders),
depression, mental health symptoms and inter-
vention satisfaction are assessed in comparison
to a waiting list control group, as well as
explored relative to a comparable ‘alcohol-only’
intervention regarding its differential effects.
▪ A limitation of the study is that only self-report
measures are used.
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disorders occur simultaneously in the same person. In
the general population, the most frequent of these is the
combination of alcohol use disorder and depression
and/or anxiety disorder.5–7 Comorbidity of alcohol
abuse and dependence is two to three times higher for
those who suffer from depression than for those in the
general population.8 Moreover, risky alcohol use is asso-
ciated with a higher probability of developing affective
disorders than for not at-risk users.9
In recent years, treatment models that target at-risk
populations have been developed and tested in rando-
mised controlled trials (RCTs).10 In addition, internet-
based interventions for individuals with different forms
of problematic substance use11–18 and/or subclinical
mental health symptoms19 were recently developed.
These internet-based interventions reach at-risk indivi-
duals at early stages of potentially more pronounced
mental health disorders.
By now, internet-based interventions have been con-
ducted as RCTs to reduce or quit the use of tobacco,20
alcohol,17 cannabis,13 15 cocaine12 and amphetamine-type
stimulants.16 The greatest effect sizes have consistently
been reported for internet-based self-help interventions
that aim to control and/or reduce consumption of
alcohol misusers by means of cognitive behavioural
therapy (CBT) with a pooled effect of Hedges’s g=0.20
(95% CI 0.13 to 0.27), as presented in a meta-analysis.17
These interventions have been proven to be safe for adult
alcohol misusers.18
Computerised and, more recently, internet-based treat-
ments for depression have been developed and proven
effective in controlled trials, both for adults21 and ado-
lescents.22 Richard and Richardson23 reported a pooled
effect size of d=0.56 (CI 0.71 to −0.41) in their
meta-analysis of comparisons between internet-based
and other computerised psychological treatments versus
control groups.
High rates of co-occurring depression symptoms and
substance use and associated negative impacts on the
course of the illness and treatment outcomes have been
well established.24 Riper et al25 demonstrated that CBT
in combination with motivational interviewing (MI)—
predominantly delivered in face-to-face therapy—proved
effective for treating subclinical and clinical alcohol use
disorders and major depressive disorders (combined
treatment), as compared with controls, with small overall
effect sizes at post-treatment (g=0.17, CI 0.07 to 0.28 for
decrease in alcohol consumption and g=0.27, CI 0.13 to
0.41 for decrease in symptoms of depression, respect-
ively). An important ﬁnding was that there were analo-
gous effects for subclinical depression and substance use
disorders, as this is relevant for the internet-based target-
ing of such individuals. Furthermore, they found that a
greater number of CBT/MI sessions was signiﬁcantly
associated with better alcohol outcomes, but not with
the depression outcomes.
For patients with dual diagnosis disorders, integrated
treatment—with treatment elements to reduce both
alcohol use and depression symptoms—can reduce treat-
ment duration and increase patients’ treatment satisfac-
tion to a greater extent than non-integrated treatment.26
Thus, integrated treatments may be more cost-effective.
A brief internet-based intervention for co-occurring
depression and problematic alcohol use in young people
(N=104) had been shown to be effective for both out-
comes in the short term when compared with an atten-
tion–control condition.27 However, no study has been
conducted to examine the effects of integrated internet-
based self-help interventions in adults. Therefore, our
study aims to investigate the efﬁcacy and cost-
effectiveness of the internet-based self-help intervention
Take Care of You (TCOY), which incorporates adherence-
focused guidance to target comorbid problematic
alcohol use and depression symptoms in adults. The
study is designed as a three-arm RCT with a combined
intervention for alcohol misuse and depression, an inter-
vention focusing on alcohol only and a waiting list. We
expect that the combined intervention will give greater
improvements in depression symptoms and treatment
satisfaction than the alcohol-only intervention, but with
similar reductions in alcohol-related outcomes.
METHODS AND ANALYSES
Study design
A three-arm RCT will be conducted to evaluate the web-
based self-help intervention TCOY with and without
modules for depression symptoms compared with a
waiting list control. Assessments will take place before
the allocation to the study conditions (T0), as well as at
6 weeks (T1), and 3 and 6 months (T2/3) after the allo-
cation (ﬁgure 1). All procedures involved in the study
will be consistent with the generally accepted standards
of ethical practice and the trial is registered at Current
Controlled Trials and traceable as ISRCTN10323951.
Recruitment of study participants
Potential participants will be recruited from February
2016 to January 2018 through the corresponding inter-
net health portals or internet websites and by advertise-
ments in commuter newspapers for each country
separately. Speciﬁc study advertisements will be placed
on relevant online health portals in the Netherlands,
Germany and Switzerland.
Registration and consent procedure
Potential participants will ﬁrst read the study informa-
tion about the background rationale and then be
informed of the following: (1) study inclusion and exclu-
sion criteria (see table 1); (2) the potential risks of par-
ticipation; (3) safety arrangements during and after the
study phase; (4) that TCOY cannot replace face-to-face
therapy for alcohol misuse and (5) the circumstances
under which they should contact their general practi-
tioner (GP) or a professional from a medical advisory
and emergency list that will be accessible at all times via
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a menu item ‘Help me’. Access will be granted to parti-
cipants during and after the study participation until the
6 months follow-up, regardless of whether they withdraw
or drop out from the study. Potential participants who
screen positive for suicidal ideations or plans are
excluded from the study (see table 1) and will be
referred to their family doctor for additional screening
or help by a staff member. The participants will also be
informed of the approval of the study by the corre-
sponding ethics committee in each country. Moreover,
they will be informed of their right to withdraw from the
study at any time without consequences.
Figure 1 Trial flow chart. This
figure provides an overview of the
participant flow for this trial.
Table 1 Inclusion and exclusion criteria and rationale
Inclusion criteria Reasoning
(1) Minimal age of 18 years To ensure a minimum age of participation
(2) AUDIT score ≥8 (and in the Netherlands: an AUDIT
score <20)
To include alcohol users with at least harmful or hazardous
alcohol use (and in the Netherlands, to exclude alcohol users
likely to meet dependence criteria)
(3) To have a CES-D-20 score ≥16 and ≤32 To include participants with at least significant or mild depression
symptoms
(4) To have at least weekly internet access To ensure minimal access to intervention
Exclusion criteria Reasoning
(1) Participation in other psychosocial or pharmacological
treatments for the reduction/cessation of alcohol use or
the reduction of depression symptoms
To avoid confounding treatment effects
(2) Use of opioids, cocaine or amphetamine-type
stimulants in the past 30 days and/or cannabis use for
more than three times a week in the previous 30 days
To avoid confounding drug effects
(2) Ever been in treatment for cardiovascular problems To avoid the possibility of participants with these problems
entering the study
(3) Suicide attempt history, actual suicide plans, elevated
probability for a suicide attempt (P4 suicidal screener
score ‘minimal risk’)
To avoid the possibility of participants with these problems
entering the study
(4) For female participants: pregnancy or breastfeeding To avoid the possibility of women with these conditions entering
the study
AUDIT, Alcohol Use Disorder Identification Test; CES-D, Centre of Epidemiologic Studies of Depression Scale.
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The registration for a personal online account involves
providing a nickname, email address, sociodemographic
data and informed consent. In Switzerland and
Germany, informed consent is given online by ticking
check boxes, while in the Netherlands users are
instructed to print and sign by hand the informed
consent form and send it to the country-speciﬁc study
coordinator. After submitting the online registration, the
system sends an email with a validation link to conﬁrm
the user’s email address. After clicking that link, they
have to set a password which completes the registration
process. The AUDIT and the Centre of Epidemiologic
Studies of Depression Scale (CES-D-20) are the main
instruments for the participant screening. Those who
fulﬁl the ordinary criteria (AUDIT ≥8 (and in the
Netherlands <20) and CES-D-20 ≥16 and ≤32, see
table 1) will take part in the regular study. Those who
do not may still fulﬁl the criteria for one of two substu-
dies with different consent procedures. The ﬁrst sub-
study is for those with an AUDIT ≥8 and a CES-D <16
and will compare the alcohol-only intervention with the
waiting list control condition. The second is for those
with an AUDIT <8 and a CES-D ≥16 and will evaluate a
transdiagnostic intervention for subthreshold depres-
sion. Participants who do not meet any of those require-
ments will be given notice that they cannot take part in
the study, but can use the programme on their own.
Additionally, they will be encouraged to seek help from
local counselling services.
Randomisation and trial flow
Figure 1 provides an overview of the trial ﬂow. If a par-
ticipant successfully completes the baseline assessment
(T0), he or she will be randomised and introduced to
the corresponding study arm (study arms 1 and 2), or
informed that they will be provided access to the inter-
vention of study arm 1 after 6 months (waiting list condi-
tion, arm 3). A computer program will automatically
randomise the participants for each country at a 1:1:1
ratio to 1 of 3 parallel groups, if they meet the require-
ments of the main study. If they only meet the require-
ments of the substudy, they will instead be automatically
assigned at a 1:1 ratio to 2 of the 3 parallel groups. The
randomisation process is partially restricted, in the sense
that the same IP is assigned to the same group for the
rest of the day, in order to prevent circumvention of the
assigned group by registering multiple accounts.
At the 3 and 6 months follow-up (T2, T3), a research
assistant will try to assess as many participants as pos-
sible, regardless of how long they remained in their
study arm or on the particular study arm they were allo-
cated to. Follow-up assessment will be performed in
three steps. First, participants will be invited up to three
times with email reminders. Should participants fail to
complete the follow-ups despite the reminder, they will
be contacted personally and motivated to complete the
follow-up instrument, and offered an interview with
study collaborators (telephone numbers will be recorded
in the consent procedure, as an integral part of the
study, in case there are contact problems at the follow-up
assessment). In case participants refuse the telephone
interview, they will be offered an interview on the
primary outcome only. If participants still refuse, they
will be asked to provide reason(s) for their refusal,
which will be documented. Apart from active withdrawal
of informed consent, we do not maintain any speciﬁc
criteria for dropouts. We learnt from the consumption
diaries of earlier studies11–14 that a substantial number
of participants take breaks for 2 or more weeks during
the interventions (eg, due to holiday absences) and
ﬁnish the intervention several weeks later.
Intervention
The internet-based interventions in study arms 1 and 2
contain eight modules based on CBT28 and MI
approaches29 to treat alcohol use disorders. Adherence-
focused guidance in study arms 1 and 2 is mainly based
on the supportive-accountability model of providing
guidance in internet interventions30 and was implemen-
ted as in previous studies.31 32 The intervention in study
arm 1 contains behavioural self-help exercises targeting
depression symptoms, alcohol misuse33 and social
problem solving.34 The elements targeting depression
symptoms are based on evidence-based treatment
modules that have been tested in a number of different
settings, including the treatment of subthreshold depres-
sion, major depression and depression in people with
chronic somatic conditions.19 32 35–38 Study arm 2 con-
sists of the self-help exercises on alcohol misuse only.
Allocation of participants to study arms 1 and 2 is
blinded. Participants in study arm 3 are placed on a
waiting list, are not blinded for their allocation and form
a control group that can access the intervention in study
arm 1 after their 6 months follow-up assessment.
Intervention modules
The eight modules are offered as an internet-based self-
help intervention (study arms 1 and 2) and are access-
ible after successful registration, providing informed
consent, and completion of the baseline assessment. In
case participants have questions regarding these
modules or face problems, they can contact their per-
sonal e-coach during the 6 weeks of the intervention.
After completing an introduction module, the starting
page will display explanations on the alcohol consump-
tion diary (study arms 1/2) and the mood and activity
diary (study arm 1), the modules and the inputs.
Participants will be introduced to six companions who
will support them and provide their own experiences to
the module tasks, and they will learn about the weekly
email reminder for programme continuation as a
further means of support. All eight modules are freely
accessible from the start under the menu item
‘modules’ (see ﬁgure 2). It is recommended that these
modules should be worked through in the order they
are presented, although any order is feasible. They
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might, for instance, jump right to the craving module if
they suffer a strong craving. Participants are recom-
mended to repeat the modules as often as needed. The
participants’ progress is indicated with a progress bar for
each module separately. If they leave a module (on
purpose or accidentally) and revisit it later, they will
automatically continue on the page they had left. They
can always navigate forward and backward and jump
back to the beginning of a module when they have ﬁn-
ished it. The detailed structure of the eight modules in
study arms 1 and 2 is presented in table 2. In order to
minimise module length as a possible confounding
factor, we designed the corresponding modules to have
the same approximate word count.
Personal companion
During the introduction, six possible ﬁctional compa-
nions are brieﬂy introduced. These are slightly different
for study arms 1 and 2 (6 companion proﬁles each).
Their function is to provide participants with situational
advice and examples. They appear in each module at
least once. The characters vary in sex, age, familial and
professional situation, in order to provide a maximum
of identiﬁcation. At the start, all participants will choose
the companion they can most identify with. That
companion’s statement will always be displayed ﬁrst, but
the statements of the other companions can still be
browsed.
Forum
Participants in study arms 1 and 2 can also exchange
messages in separate forums with other participants of
their allocated study arm. Forum activities are recom-
mended to increase the success of the intervention.
A forum administrator with a clinical and health psych-
ology background will moderate both forums, in order
to check and to delete inappropriate contents.
Adherence-focused guidance and intervention reminders
The two active study arms 1 and 2 will include e-coaches
to provide adherence-focused guidance. The purpose of
the guidance is to support participants’ adherence to
the treatment modules while minimising the project
team’s expenditure. In line with the supportive account-
ability model,30 it is assumed that adherence to an
internet-based intervention (and thus its effectiveness)
can be enhanced by support from a coach who is seen
as legitimate, trustworthy, benevolent and expert. The
e-coach guidance will consist of two elements: (1) adher-
ence monitoring and (2) feedback on demand.
Adherence monitoring will include offering participants
support in adhering to the intervention by regularly
checking whether they have completed intervention ses-
sions on time and, if not, by reminding them to do so
and to reinforce their adherence. Both personal and
automatic reminders have been shown to improve
adherence to self-guided health promotion and
Figure 2 This figure provides an
overview of the Take Care of You
main menu for the reduction of
alcohol use and depression
symptoms in alcohol misusers
with co-occurring depression
symptoms.
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Table 2 Module contents and comparison between alcohol and depression self-help (arm 1) and alcohol self-help only (arm 2)
No Arm 1: alcohol and depression self-help Arm 2: alcohol self-help only
M1 Introduction (1750 words)
▸ Introductory words (tailored to arm 1)
▸ Pro and contra of drinking
▸ Core motive for change
▸ Confidence of change
▸ Introduction to consumption diary, mood barometer and
planning of positive activities
Introduction (1700 words)
▸ Introductory words (tailored to arm 2)
▸ Pro and contra of drinking (same as arm 1)
▸ Core motive for change (same as arm 1)
▸ Confidence of change (same as arm 1)
▸ Introduction to consumption diary
mandatory
M2 Strategies for goal achievement (2370 words)
▸ Introduction (80 words)
▸ Changing habits (500 words)
▸ Alcohol at home (860 words)
– Exercise: resisting alcohol in specific situations for the
dimension availability and mood
Reflections on mood
Drinking in positive situations
Drinking in negative situations
▸ Thanks, I don’t drink (160 words)
▸ Alcohol for relaxation
(Short version without link to M7)
▸ My personal strategies (tailored to arm 1)
Strategies for goal achievement (2825 words)
▸ Introduction (same as arm 1)
▸ Changing habits (same as arm 1)
– Alcohol at home (same as arm 1)
– Exercise: resisting alcohol in specific
situations for the dimension availability and
mood
– Reflection on availability
Alcohol at home: no good for me
Alcohol at home: no issue for me
▸ Alcohol for relaxation
(Short version with link to M7—PMR)
▸ My personal strategies (tailored to arm 2)
M3 Say yes (2330 words)
▸ Positive activities (1400 words)
– Checkbox list with around 80 activities of 5 categories
social, leisure time, relaxation, creativity, sports, culture
– Incorporation in daily life
▸ Common problems (930 words)
– Tips for motivational problems
– Tips for implementation problems
Say no (2630 words)
▸ Thanks, I don’t drink (1700 words)
– Difficulties with rejecting offered alcohol
(impolite, shame, outsider, problem outing)
– Exercise saying no
– Strategies against ‘persistent seducers’
– Role-playing exercises
▸ Common problems (930 words)
– Tips for motivational problems
– Tips for implementation problems
M4 Worries and problems (1850 words)
▸ Relation of depression and problems
▸ 6-step plan
– My problem
○ Controllable problem
○ Uncontrollable problem
– My goal?
– Possible solutions
– Planning of route to goal
– Try out the route
– Review and taking stock
Identify risk situations (1550 words)
▸ Identify risk situations
– In negative emotions
– In positive emotions
– For relief/relaxation
– Habits
▸ What now?
– Seemingly unimportant decisions
M5 Craving (1300 words)
▸ Forms of craving (physical and mental)
▸ Craving and conditioned triggers
▸ How to handle craving
– Distract yourself
– Talk about it with someone
– Just be aware of it
– Bring to mind all negative consequences of
consumption
– Talk to yourself
Craving (same as arm 1)
M6 Dealing with slips (474 words)
▸ Define what you consider a slip
▸ How to deal with it
▸ Plan your reaction for future slips
Dealing with slips (same as arm 1)
Continued
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behaviour change interventions,39 40 but it is assumed
that personal rather than automatic reminders from a
coach are perceived as being more benevolent and
more effective. Feedback on demand provides the partici-
pants with an opportunity to contact the coach via the
platform or a standard email and to receive individual
support/feedback whenever such a need develops. In
contrast to other guidance concepts, the guidance is
provided only when requested by the participants.
Feedback is not assumed to have a direct inﬂuence on
the effectiveness of the intervention. However, it aims to
enhance the perception of the coach’s legitimacy and
the sense that the coach has the participant’s best inter-
ests at heart.41 Individuals are assumed to respond more
positively to adherence demands from a coach who is
perceived as legitimate.30 41 Hence, the perceived legit-
imacy of the coach is believed to enhance adherence to
the intervention and to constitute a necessary require-
ment if adherence monitoring is to have a positive inﬂu-
ence on the effectiveness of the intervention.
There are ﬁve types of emails that will be sent to the
participants: (1) weekly emails, (2) diary feedback, (3)
diary reminder, (4) follow-up invitations and (5) per-
sonal progression feedback. All emails are only sent to
intervention arms 1 and 2, except for the follow-up invi-
tations. (1) Weekly emails are automatically sent on the
last day of each week. Their function is to accompany
the participants through the 6 weeks with encouraging
words, and to remind them to ﬁll out the diary on the
next day and sometimes to suggest using a particular
module. (2) Diary feedback is automatically sent 2 days
after the beginning of every week, if a participant has
ﬁlled out his or her diary. Its content is a very short sen-
tence and depends on the change in consumption com-
pared with the previous week. The sentence is taken
from a pool of 3×6 messages and can be positive (in
case of a decrease in consumption), neutral (in case of
stagnation) or compassionate (in case of an increase in
consumption). (3) Diary reminders are automatically
sent if the participant has not yet ﬁlled out his or her
diary for 1 and/or 3 days after starting the new week.
(4) Follow-up invitations are automatically sent on the
day when the person is meant to ﬁll out a questionnaire.
This is the only email that will also be sent to the waiting
list. (5) Personal progression feedback is the only type of
email that is sent manually. The ﬁrst one is a standard
email sent in the ﬁrst week, in which the e-coach intro-
duces himself or herself, with an offer of contact if there
are questions or problems during the 6 weeks of study
participation. Further emails are sent manually in prede-
ﬁned circumstances. There are two main types of cir-
cumstances when such emails are sent—ﬁrst, when
participants progress too slowly or too rapidly through
the modules, and second, when participants have given
certain answers in particular modules. In the latter case,
particular suggestions are provided. For example, if a
participant has ticked that he/she often drinks alcohol
when ‘invited for drinks’, ‘after work with colleagues’ or
‘when alcohol was available for free’ in the module
‘identify risk situations’, the e-coach can suggest that
he/she should look into the module ‘Say no!’, if he/she
has not yet done so. For easy administration, the e-coach
will be given online access to several customised user
lists showing only participants who have ticked off those
answers and the page they have reached in the module
we wish to recommend. The email itself has to be trig-
gered and entered manually, but can be sent to multiple
users from the administration backend.
Technical specifications
TCOY is a website that is based on Drupal 7 and incor-
porates the self-help parts of a previously implemented
design.11–14 The website has a responsive design and
automatically adapts to tablets and smartphones.
Participants are informed that they can also use their
mobile devices. Any internet user can register an online
account via one of the country-speciﬁc internet websites
of TCOY (http://www.takecareofyou.nl, http://www.
Table 2 Continued
No Arm 1: alcohol and depression self-help Arm 2: alcohol self-help only
M7 Meeting your needs (2650 words)
▸ Sleep: tips for better sleep hygiene
▸ Rumination: 6 ways to deal with it
– Become aware of it
– Stop your thoughts
– Let them pass (including an audio file of 5 min)
– Relax
– Appreciate the positive; diary of gratitude
– Tackle problems (referring to M3)
▸ Social contacts: importance of and how to (re)inforce them
Progressive muscle relaxation (770 words)
▸ Basic overview
▸ FAQ
▸ Exercise in written words
▸ Guided instructions via audio file (15 min)
▸ Training in daily life
M8 Preserve success (750 words)
▸ Your toughest moments?
▸ Most helpful modules?
▸ Your top 5 strategies?
▸ Preserve success (same as arm 1)
FAQ, frequently asked questions; PMR, progressive muscle relaxation.
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takecareofyou.de, http://www.takecareofyou.ch), by pro-
viding a unique username and email address. These
three websites are technically independent installations
with separate databases and user management.
To prevent the creation of accounts with invalid email
addresses, the registration process will not be completed
until a veriﬁcation email link has been clicked and a per-
sonal password has been set. To prevent evasion of the
assigned group by registering a second account, we have
implemented a mechanism to assign users with the
same IP to the same group for the rest of the day.
Waiting list condition
Participants randomised to the waiting list will have the
opportunity to participate in the internet-based interven-
tion (study arm 1) 6 months after registration. Healthcare
utilisation will be monitored closely in all groups.
Measurements
Table 3 presents an overview of the measurements used
at baseline, as well as after 6 weeks in treatment and
after 3 and 6 months follow-up.
The primary outcome measure comprises the quantity
of alcohol use in the previous 7 days in number of stand-
ard drinks and will be assessed by timeline follow-back, a
widely used measure in studies aiming at controlled
drinking (timeline followback; TLFB).42
The secondary outcome measures consist of the fol-
lowing measures: (1) the total score of the short version
of AUDIT-C.43 We will also assess the full second edition
of the AUDIT4 assessment at baseline, for a more com-
prehensive screening of alcohol use disorders and for
comparisons with participants of other studies. An
AUDIT score of ≥8 is used to identify harmful or hazard-
ous alcohol use in both sexes. (2) The CES-D-20.44 45
The CES-D scale is a short self-report scale designed to
measure depression symptoms in the general popula-
tion.44 45 The items of the scale are symptoms associated
with depression that have been used in previously vali-
dated longer scales. The CES-D scale has been tested in
household interview surveys and in psychiatric settings
and found to have very high internal consistency and
adequate test–retest reliability. CES-D responses are
based on the frequency of occurrence of depression
symptoms during the past week. It uses a four-point
ordinal scale: rarely or none of the time (<1 day); some
or a little of the time (1–2 days); occasionally or a mod-
erate amount of the time (3–4 days); most or all of the
time (5–7 days). The scores of the CES-D-20 range
between 0 and 60. A CES-D-20 cut-off score of 16 is indi-
cative of ‘signiﬁcant’ or ‘mild’ depression symptoms. It is
equivalent to experiencing six symptoms for most of the
previous week or a majority of symptoms on 1 or 2 days.
Higher scores indicate a higher symptom load. In order
to prevent individuals with more severe depression symp-
toms entering the study, participants with a CES-20 score
higher than 32 will be excluded from the sample after
the study but offered access to the intervention and
recommended additional face-to-face treatment. (3)
A combined alcohol and depression symptoms measure,
falling below the AUDIT-C cut-off of 4 in women and 5
in men (no more severe alcohol use disorder according
to the Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition (DSM-V))46 and the CES-D-20
cut-off of 16 (no more signiﬁcant or mild depression
symptoms). This measure is calculated during the inter-
vention analyses. (4) The number of alcohol-free days
per week assessed by TLFB.42 (5) The ‘Fragebogen
Substanzanamnese’ (FDA) that ascertains the years of
lifetime consumption, the past month’s consumption,
Table 3 Measurements and instruments
Assessments/instruments Baseline 6 weeks 3-month follow-up 6-month follow-up
Sociodemographics x
FDA x
AUDIT x
AUDIT-C x x x
CES-D-20 x x x
AUDIT-C<4 in women and <5 in men and CES-D-20<16 x x x
Number of consumption free days* x x x
Number of weekly standard drinks* x x x
MHI-5 x x x
Suicidal ideations or plans x x x
EQ-5D-5L x x x
TiC-P x x x
WAI presenteeism x x x
ZUF-8† x
*Based on the TLFB method.
†This instrument will only be applied to intervention arms 1 and 2.
AUDIT, Alcohol Use Disorder Identification Test; CES-D, Centre of Epidemiologic Studies of Depression Scale; EQ-5D-5L, five-level variant of
the five-dimensional EuroQol instrument; FDA, food and drugs administration; TiC-P, Trimbos and iMTA questionnaire on ‘Costs associated
with Psychiatric Illness’; WAI, Work Ability Index.
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and the manner of consumption for the DSM-IV/
International Classiﬁcation of Diseases (ICD)-10 sub-
stances of abuse. This measure was derived from the
EuropeASI.47 (6) The short version of the Mental
Health Inventory (MHI-5).48 This is a validated and user-
friendly self-assessment questionnaire that assesses
recent mental distress and self-reported diagnoses of
depression. In addition, we will also ask participants to
indicate any suicidal or self-harm ideations or plans at
the follow-ups. (7) The quality of life is measured by the
ﬁve-level variant of the ﬁve-dimensional EuroQol instru-
ment (EQ-5D-5L), a standardised instrument used as a
measure of health outcome that provides a simple
descriptive proﬁle and a single index value for health
status.49 (8) Direct medical and direct non-medical cost
data are collected with the Trimbos and iMTA question-
naire on ‘Costs associated with Psychiatric Illness’
(TiC-P).50 (9) Work ability is measured by the single
item Work Ability Index (WAI).51 (10) Treatment reten-
tion is calculated as the percentage of completed weekly
consumption diary entries (study arms 1 and 2). (11)
The German client satisfaction questionnaire ZUF-8 has
been extensively studied, and is easily scored by
summing the individual item scores to produce a range
of 8–32, with high scores indicating greater satisfac-
tion.52 53 In study arms 1 and 2, participation in the
intervention as an indicator of treatment adherence will
be measured through diary entries, the number of com-
pleted modules, and the number of logins in the login
history between the baseline assessment and the
6-month follow-up. (12) Lastly, the occurrence of any
negative effects will be identiﬁed as in Rozental et al54 at
the 6 months follow-up.
German and Dutch validations are available for all
outcome instruments. Unit resource use (GP visits, ill
days, etc) will be multiplied by their appropriate integral
country-speciﬁc cost prices for the TiC-P.
Sample size calculation
An estimation of the effect sizes is necessary because of
a lack of comparable internet-based self-help studies that
address both problematic alcohol use and depression
symptoms. On the basis of an expert opinion, we can
postulate a small effect size with Cohen’s d=0.25 for the
reduction in the weekly number of standard drinks
between study arms 1 and 3 at 6 months postrandomisa-
tion. We aim to include 756 participants for all three
countries and study arms, 100 in the Netherlands and
328 each in Switzerland and Germany. This sample size
will allow us to detect an effect size of d=0.25 based on a
power (1−β) of 80% and an α error of 0.05 in a two-
sided test, calculated using G*Power software.
Data analyses
Data will be analysed according to the intention-to-treat
(ITT) principle. To address missing data for the ITT
analyses, we will apply multiple imputation procedures
of R (R Foundation for Statistical Computing, Vienna)
with Amelia-2. Differences between study arms in
primary and secondary continuous outcome variables at
baseline and the follow-up points will be tested using
(robust/generalised) linear mixed models (LMMs).
LMMs will be speciﬁed appropriately to model clusters
and repeated measures by deﬁning random effects for
study arms and time (repeated measures). For non-
normal continuous outcomes, appropriate distributions
(eg, negative binomial, zero-inﬂated) will be speciﬁed.55
Appropriate covariance matrices for the random effects
will be used. For binary outcomes, a generalised LMM
(GLMM) will be speciﬁed that deﬁnes an appropriate
link function. In the GLMM ﬁxed effect, coefﬁcients will
be interpreted in the context of the participant-speciﬁc
(non-marginal) model ﬁt. In order to investigate the
exploratory research question as to whether combined
treatment for depression and alcohol results in a similar
reduction in alcohol consumption as with alcohol treat-
ment alone, a CI approach will be used for the effect
size of the difference between the two study arms, with a
two-sided 0.05 level of signiﬁcance.56 The equivalence
margin is a priori set at d=0.20, corresponding to the
smallest value that would present a relevant effect.57 The
upper bound of the 95% CI for the effect size will be
compared with the predeﬁned equivalence margin of
d=0.20 and will have to be below the margin to show
equivalence. In addition to the ITT analyses, per-
protocol analyses will be performed.
Economic evaluation
Costs
We will consider four types of costs: (1) the costs of
offering the TCOY interventions, (2) costs stemming
from general healthcare uptake besides the TCOY inter-
ventions, including the costs of medication, (3) patients’
out-of-pocket expenses (eg, leisure time spent on receiv-
ing care) and (4) costs stemming from productivity
losses due to absenteeism or reduced efﬁciency while at
work (presenteeism). The ﬁrst two types of costs are also
known as the direct medical costs and these will be
based on the full economic costs of offering the inter-
ventions. Here, we will use national guidelines for eco-
nomic evaluation (ie, for the Netherlands;50 for
Germany and also for Switzerland as there are none for
Switzerland),58 59 and rely on the standard cost prices
reported therein. Productivity losses will be based on the
sex-speciﬁc and age-speciﬁc labour costs for each of
the three countries. Data on resource use (healthcare
uptake) and productivity losses will be collected with the
widely used TiC-P.60
Effects
As an effect measure, the EQ-5D-5L61 will be used to
compute health gains expressed in quality-adjusted life
years (QALYs). Health utilities are a major feature of the
EQ-5D instrument, and are available for the Netherlands62
and Germany.63 For Switzerland, the German tariffs will
be used as there are no EuroQol-recognised German-Swiss
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health utilities for the EQ-5D available. Since the
EQ-5D-5L is a recent update of the three-level EQ-5D,
studies that directly elicit preferences from general popula-
tion samples to derive value sets to calculate the EQ-5D-5L
health utilities are currently under development (EuroQol
group 2015).64 In the meantime, the EuroQol Group has
coordinated a study that administered both the three-level
and ﬁve-level versions of the EQ-5D, in order to develop a
‘crosswalk’ between the EQ-5D-3L and the EQ-5D-5L. This
has resulted in crosswalk value sets for the EQ-5D-5L.65 It
is expected that the new utilities for the EQ-5D-5L will be
available before we perform the economic evaluations for
the current project; otherwise, the crosswalk from the
EuroQol Group will be used to calculate health utilities.
Cost-effectiveness calculations
The economic evaluation will be conducted alongside
the randomised trial, taking into account the CHEERS
statement66 and the 2015 ISPOR good research practices
task force report on cost-effectiveness analysis alongside
clinical trials.67 From the technical point of view, the
economic evaluation referred to as cost-effectiveness
analysis in the following section will be both a cost-
effectiveness analysis and a cost-utility analysis. For the
cost-effectiveness analysis, positive treatment response, a
dichotomous outcome measure, is deﬁned as falling
below the AUDIT-C cut-off for severe alcohol use dis-
order and the CES-D-20 cut-off of 16 (no more signiﬁ-
cant or mild depression symptoms). For the cost-utility
analysis, health utilities based on the EQ-5D instrument
will be used as the effect measure.
Using the area under the curve method, the periods
between the measurement waves will be weighted by
the utility of the health state in that period. This allows
computation of QALYs over the entire trial period
(24 weeks between randomisation and the last follow-up
wave) for the cost-utility analysis. In a similar vein,
cumulative costs over the entire follow-up period will be
obtained from the cost estimates at the various meas-
urement waves. The cost-effectiveness and cost-utility
evaluations will be performed in line with suggestions
by Drummond et al,68 that is, in agreement with the
ITT principle, with missing data addressed using
imputation.
The incremental cost-effectiveness ratio (ICER) will be
calculated as follows: ICER=(C1−C2)/(E1−E2), where
C stands for costs, E for effects (either the average
change in QALYs or the proportion of participants
meeting criteria for positive treatment response), and
subscripts 1 and 2 refer to the two trial arms compared.
Since this study comprises three trial arms, three such
comparisons will be analysed and presented. CIs around
the ICER will be calculated using a non-parametric boot-
strap approach: 5000 non-parametric bootstrapped
samples will be extracted from the original data set. For
each of these bootstrapped samples, the incremental
costs, incremental effects and the ICER will be calcu-
lated for each comparison between two of the three trial
arms separately. The resulting 5000 ICERs will be used
for further calculations and will be plotted on a cost-
effectiveness plane. In addition, cost-effectiveness accept-
ability curves (CEACs) will be constructed. One-way sen-
sitivity analyses directed at uncertainty in the main cost
drivers will be performed to gauge the robustness of our
ﬁndings. In addition, a sensitivity analysis in which a
covariate-adjusted CEAC curve is constructed will be con-
ducted using net beneﬁt regression methods.69 70
Ethics and dissemination
The ethics committee of Leuphana forewent a separate
ethics procedure, as the study had already been approved
in Switzerland. The trial is registered at Current
Controlled Trials and traceable as ISRCTN10323951.
Results will be reported at conferences and in peer-
reviewed publications. A participant-friendly summary of
trial ﬁndings will be published on the TCOY websites in
each participating country.
DISCUSSION
To the best of our knowledge, this will be the ﬁrst RCT
to compare the efﬁcacy and cost-effectiveness of an
internet-based self-help intervention with adherence-
focused guidance for alcohol misuse and depression
symptoms, in comparison to internet-based self-help
with adherence-focused guidance for problematic drink-
ing only in an at-risk general population sample. The
expected ﬁndings will extend our insights in designing
effective internet-based interventions in general and
more speciﬁcally for comorbid alcohol use disorder and
depression. In particular, this easy to access and anonym-
ous intervention may be of special beneﬁt for otherwise
well-integrated individuals who suffer from depression
symptoms and fear stigmatisation for their alcohol
misuse and who therefore fail to visit addiction counsel-
ling and treatment centres.
To the best of our knowledge, there are no available
data on comparative cost-effectiveness studies of
internet-based indicated prevention or dual-disorder
treatments of alcohol and depression versus alcohol
treatment alone.
Since the objective is to reduce alcohol misuse and
depression symptoms, it makes sense to tackle both pro-
blems in the same self-help intervention and some
underlying theory is explicitly introduced in the com-
bined alcohol and depression self-help intervention.
However, it was challenging to compile and develop this
combined intervention. First, we decided to follow the
results of the meta-analysis of Riper et al25 that looked at
face-to-face interventions. This meta-analysis only
focused on studies that included CBT and MI, since
these therapeutic approaches have been shown to be
superior to others in previous studies on the treatment
of comorbid alcohol use disorder and depression.71 This
meta-analysis implies that a combined intervention has
to include rather more modules addressing problematic
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drinking than depression symptoms and that integrated
interventions do not perform better than interventions
including modules addressing one problem after the
other. Second, we had to adjust this combined interven-
tion to the lengths of the alcohol self-help only study
arm, in order to avoid the possibility that intervention
length has an inﬂuence on outcomes of the two respect-
ive study arms. Third, we decided that the maximal
number of modules to be included was eight. Moreover,
we aimed for concise modules in order to avoid early
dropouts after successful study registration. Thus, the
content of the combined alcohol and depression inter-
vention (study arm 1) is sometimes integrated (eg,
reﬂections on mood in module 2, strategies for goal
achievements) and sometimes replaced with a com-
pletely new depression module (eg, module 3 on activity
planning replaced module 3 of the alcohol only inter-
vention that aims at fostering alcohol-related refusal
skills). Moreover, some modules were shortened to
reach comparable intervention lengths without losing
relevant concepts (eg, module 3 of study arm 2 that
aims at fostering alcohol-related refusal skills was shor-
tened and inserted into module 2 of study arm 1).
However, this study allows us to answer the question as
to whether an internet-based intervention to target two
inter-related mental health problems (problematic
alcohol use and depression symptoms)—either inte-
grated or consecutive—is better than an intervention of
comparable length addressing alcohol use problems
only. Moreover, we expect the planned study to extend
our knowledge as to whether integrated dual diagnosis
interventions lead to higher intervention satisfaction
than treatment interventions without explicit focus on a
dual diagnosis.27 One of the advantages of TCOY is its
responsive web design that also allows mobile phone par-
ticipation. We hope that participants will more fre-
quently ﬁll out their consumption and mood diary and
potentially provide diary entries that are more valid and
not too dependent on retrospective distortions. On the
other hand, we expect that distraction during longer
and more complex tasks will be rather high when parti-
cipants are on the move. Therefore, we also recommend
that participants should take enough time—at least once
a week—to complete their modules in a calm place.
Aside from the large sample size needed for the
alcohol and depression group, there are other reasons
why we sought collaboration in multiple countries, even
from the early stage of the TCOY project. Disease and
disability are not stopped by national borders and espe-
cially not limited to borders when delivered through the
internet. In addition, participation rates may depend on
the distance to the nearest mental health centre. For
example, for rural areas in Switzerland, these distances
will be higher and may result in a greater treatment
adherence to TCOY, whereas in a densely populated
country such as the Netherlands, there may be more
rapid transfer from the TCOY intervention to local
mental healthcare.
Limitations
This study has the following limitations. First, the exclu-
sion of people who are currently receiving psychosocial
or pharmacological treatments to support reducing or
quitting alcohol use and depression symptoms is an
important limitation. However, this study aims at testing
the efﬁcacy of an internet-based self-help intervention
for people with co-occurring problematic alcohol use
and depression symptoms who are not likely to seek
traditional treatment services due to stigma, anxiety or a
lack of time resources.
Second, owing to limitations with regard to feasibility,
only self-reported measurements will be used. Third,
most of the self-report instruments show good psycho-
metric properties, but only a few have been validated in
the context of online assessments, for example, the
TLFB.42 Finally, the expected high attrition rates in
study arms 1 and 2 during the 6 weeks of the interven-
tions will be a major limitation of this study. We will
address this issue in four ways: (1) all participants will be
asked to invest ∼25 min on the baseline assessment,
which may select more motivated participants and
prevent participation of unmotivated participants; (2)
participants will be sent adherence-focused weekly
motivational reminder emails; (3) we have integrated ﬁc-
tional personal companions and have provided the users
with the possibility to share their personal intervention
progress and experiences in a forum with their partici-
pating peers, in order to increase personal commitment.
Last but not least, all missing values in the ﬁnal data set
will be imputed for ITT analyses in addition to per-
protocol analyses, as we expect high levels of study drop-
outs at the follow-ups and want to estimate the sensitivity
of our ﬁndings to the approach chosen for missing data.
CONCLUSION
This study allows one to assess the (cost-)effectiveness of
an internet-based intervention for reducing co-occurring
alcohol misuse and depression symptoms simultaneously.
If shown to be effective, the TCOY intervention is a valu-
able means to reach people in the general population
who do not use traditional mental healthcare and addic-
tion counselling services.
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